No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:128152600-128165800 |
Weak transcription |
Aorta |
Aorta
|
2 |
chr2:128157000-128165400 |
Weak transcription |
Psoas Muscle |
Psoas
|
3 |
chr2:128161400-128165400 |
Weak transcription |
Ovary |
ovary
|
4 |
chr2:128162000-128165800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
5 |
chr2:128162200-128165600 |
Enhancers |
NHEK |
skin
|
6 |
chr2:128163600-128165800 |
Weak transcription |
Esophagus |
oesophagus
|
7 |
chr2:128164000-128165800 |
Enhancers |
HMEC |
breast
|
8 |
chr2:128164200-128165800 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
9 |
chr2:128164200-128165800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
10 |
chr2:128164200-128166600 |
Enhancers |
Fetal Thymus |
thymus
|
11 |
chr2:128164400-128165400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
12 |
chr2:128164400-128165800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
13 |
chr2:128164400-128166400 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
14 |
chr2:128164600-128165800 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
15 |
chr2:128164800-128165400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
16 |
chr2:128164800-128165400 |
Enhancers |
Brain Substantia Nigra |
brain
|
17 |
chr2:128164800-128165400 |
Enhancers |
Thymus |
Thymus
|
18 |
chr2:128164800-128165600 |
Enhancers |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
19 |
chr2:128164800-128165800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
20 |
chr2:128164800-128165800 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
21 |
chr2:128164800-128165800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
22 |
chr2:128164800-128165800 |
Enhancers |
Small Intestine |
intestine
|
23 |
chr2:128164800-128165800 |
Enhancers |
Spleen |
Spleen
|
24 |
chr2:128164800-128166400 |
Enhancers |
NHDF-Ad |
bronchial
|
25 |
chr2:128165000-128165400 |
Flanking Active TSS |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
26 |
chr2:128165000-128165400 |
Flanking Active TSS |
HUES48 Cell Line |
embryonic stem cell
|
27 |
chr2:128165000-128165400 |
Enhancers |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
28 |
chr2:128165000-128165400 |
Flanking Active TSS |
iPS-20b Cell Line |
embryonic stem cell
|
29 |
chr2:128165000-128165400 |
Flanking Active TSS |
Primary hematopoietic stem cells |
blood
|
30 |
chr2:128165000-128165400 |
Flanking Active TSS |
Primary T helper memory cells from peripheral blood 1 |
blood
|
31 |
chr2:128165000-128165400 |
Enhancers |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
32 |
chr2:128165000-128165400 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
33 |
chr2:128165000-128165400 |
Enhancers |
Fetal Adrenal Gland |
Adrenal Gland
|
34 |
chr2:128165000-128165400 |
Enhancers |
Pancreatic Islets |
Pancreatic Islet
|
35 |
chr2:128165000-128165400 |
Flanking Active TSS |
A549 |
lung
|
36 |
chr2:128165000-128165600 |
Flanking Active TSS |
Skeletal Muscle Male |
skeletal muscle
|
37 |
chr2:128165000-128165600 |
Flanking Active TSS |
Hela-S3 |
cervix
|
38 |
chr2:128165000-128165800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
39 |
chr2:128165000-128165800 |
Enhancers |
HUVEC |
blood vessel
|
40 |
chr2:128165000-128165800 |
Enhancers |
NH-A |
brain
|
41 |
chr2:128165000-128166400 |
Enhancers |
Primary T killer naive cells fromperipheralblood |
blood
|
42 |
chr2:128165000-128166400 |
Enhancers |
GM12878-XiMat |
blood
|
43 |
chr2:128165000-128166600 |
Enhancers |
Stomach Mucosa |
stomach
|
44 |
chr2:128165200-128165400 |
Flanking Active TSS |
ES-I3 Cell Line |
embryonic stem cell
|
45 |
chr2:128165200-128165400 |
Flanking Active TSS |
H9 Cell Line |
embryonic stem cell
|
46 |
chr2:128165200-128165400 |
Flanking Active TSS |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
47 |
chr2:128165200-128165400 |
Flanking Active TSS |
HUES6 Cell Line |
embryonic stem cell
|
48 |
chr2:128165200-128165400 |
Flanking Active TSS |
HUES64 Cell Line |
embryonic stem cell
|
49 |
chr2:128165200-128165400 |
Flanking Active TSS |
iPS-15b Cell Line |
embryonic stem cell
|
50 |
chr2:128165200-128165400 |
Flanking Bivalent TSS/Enh |
iPS-18 Cell Line |
embryonic stem cell
|